Clinical Chemistry Link to Randox Laboratories Web Site
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 54: 39-43, 2008. First published November 12, 2007; 10.1373/clinchem.2007.090134
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow HTML Page - index.htslp
Right arrow All Versions of this Article:
clinchem.2007.090134v1
54/1/39    most recent
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Vermeersch, P.
Right arrow Articles by Bossuyt, X.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vermeersch, P.
Right arrow Articles by Bossuyt, X.
(Clinical Chemistry. 2008;54:39-43.)
© 2008 American Association for Clinical Chemistry, Inc.


Opinion

A Critical Appraisal of Current Practice in the Detection, Analysis, and Reporting of Cryoglobulins

Pieter Vermeersch1, Koenraad Gijbels1,2, Godelieve Mariën1, Rod Lunn3, William Egner3, Peter White3 and Xavier Bossuyt1,a

1 Department of Laboratory Medicine, Immunology, University Hospitals Leuven, Catholic University of Leuven, Belgium; 2 Current address: Department of Laboratory Medicine, Ziekenhuis Oost-Malle, Zoersel, Belgium; 3 United Kingdom National External Quality Assessment Service (UKNEQAS), Department of Immunology, Sheffield, United Kingdom.

aAddress correspondence to this author at: Laboratory Medicine, Immunology, University Hospitals Leuven, Herestraat 49, B-3000 Leuven, Belgium. Fax 0032-16-34-79-31; e-mail Xavier.bossuyt{at}uz.kuleuven.be.

To assess current practice in the detection, analysis, and reporting of cryoglobulins, a questionnaire was sent to 140 laboratories. Only 36% of laboratories used standard procedures (tube preheating, transport in container, and sedimentation and/or centrifugation at 37 °C) to ensure that the temperature did not drop below 37 °C until after serum separation. Time periods allowed for cryoprecipitation at 4 °C varied from 12 h to 9 days, with 30% of laboratories allowing precipitation for <3 days. After cryoprecipitation, 81% of laboratories resolubilized the cryoprecipitate at 37 °C, and 77% further immunotyped the cryoprecipitate. After analysis, 5% referred the sample for confirmation, 58% provided a nonquantitative report, and 37% reported the cryoglobulin concentration in the cryoprecipitate as cryocrit, total protein concentration, and/or immunoglobulin concentration. Only 3 laboratories (2%) provided cryoprecipitate-specific reference values for total protein content, and none provided reference values for immunoglobulins. We believe standardization is needed for cryoglobulin detection to avoid missed diagnoses and improve the comparability of results. Laboratories should ensure that sample temperature does not drop below 37 °C until after serum separation. The serum should cryoprecipitate at 4 °C for at least 3 (preferably 7) days. The cryoprecipitate should be washed and resolubilized at 37 °C for further analysis.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by the American Association for Clinical Chemistry.